The DIALECT research group is proud to announce the publication of a groundbreaking scientific article led by doctoral candidate Abhilasha Akerkar, in collaboration with researchers from Steno Diabetes Center Copenhagen. This study, recently published in Diabetes, Obesity and Metabolism, presents real-world evidence from a remarkable 22-year follow-up on the cumulative risk of diabetic foot complications (DFC) in individuals with type 1 and type 2 diabetes.
Key Findings
The study provides crucial insights into optimizing diabetic foot care. One of the primary findings suggests that for individuals at low risk of developing DFCs, annual foot screenings—currently the standard recommendation—might be safely extended in specific healthcare settings. This adjustment could enhance resource allocation without compromising patient care quality.
Why This Matters
Diabetic foot complications remain a major concern for individuals with diabetes, often leading to severe outcomes such as ulceration and amputation. By refining screening intervals based on patient risk profiles, healthcare providers can ensure more efficient and equitable use of medical resources. This approach supports a personalized medicine strategy, ultimately benefiting both patients and the healthcare system.
Recognizing Contributions
This milestone publication is the result of a collaborative effort by an esteemed group of researchers, including Pernille Falberg Rønn, Vanja Kosjerina, Christian Stevns Hansen, Adam Hulman, Frederik Persson, Anne Rasmussen, Peter Rossing, and Tarunveer Singh Ahluwalia. Their work represents a significant contribution to the field of diabetic foot care research.
Read the Full Study
For those interested in exploring the full findings, the published article is available at the following link: Read the article here.
We extend our congratulations to the entire research team on this important achievement and look forward to further advancements in diabetes research from the DIALECT group.